Global Opioids Drug Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 543033
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Life Sciences
|
Format : 
The global Opioids Drug market was valued at 1083.67 Million USD in 2020 and will grow with a CAGR of 1.83% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016. Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%. North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016. North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
By Market Verdors:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
By Types:
Oxycodone
Hydromorphone
Codeine
Fentanyl
By Applications:
Pain Relief
Anesthesia
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016. Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%. North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016. North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
By Market Verdors:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
By Types:
Oxycodone
Hydromorphone
Codeine
Fentanyl
By Applications:
Pain Relief
Anesthesia
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioids Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioids Drug Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.5 Market by Application
1.5.1 Global Opioids Drug Market Share by Application: 2022-2027
1.5.2 Pain Relief
1.5.3 Anesthesia
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Opioids Drug Market
1.8.1 Global Opioids Drug Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Opioids Drug Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioids Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioids Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Opioids Drug Sales Volume Market Share by Region (2016-2021)
3.2 Global Opioids Drug Sales Revenue Market Share by Region (2016-2021)
3.3 North America Opioids Drug Sales Volume
3.3.1 North America Opioids Drug Sales Volume Growth Rate (2016-2021)
3.3.2 North America Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Opioids Drug Sales Volume
3.4.1 East Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Opioids Drug Sales Volume (2016-2021)
3.5.1 Europe Opioids Drug Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Opioids Drug Sales Volume (2016-2021)
3.6.1 South Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Opioids Drug Sales Volume (2016-2021)
3.7.1 Southeast Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Opioids Drug Sales Volume (2016-2021)
3.8.1 Middle East Opioids Drug Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Opioids Drug Sales Volume (2016-2021)
3.9.1 Africa Opioids Drug Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Opioids Drug Sales Volume (2016-2021)
3.10.1 Oceania Opioids Drug Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Opioids Drug Sales Volume (2016-2021)
3.11.1 South America Opioids Drug Sales Volume Growth Rate (2016-2021)
3.11.2 South America Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Opioids Drug Sales Volume (2016-2021)
3.12.1 Rest of the World Opioids Drug Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Opioids Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Opioids Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Opioids Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Opioids Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Opioids Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Opioids Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Opioids Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Opioids Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Opioids Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Opioids Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Opioids Drug Sales Volume Market Share by Type (2016-2021)
14.2 Global Opioids Drug Sales Revenue Market Share by Type (2016-2021)
14.3 Global Opioids Drug Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Opioids Drug Consumption Volume by Application (2016-2021)
15.2 Global Opioids Drug Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Opioids Drug Business
16.1 Teva
16.1.1 Teva Company Profile
16.1.2 Teva Opioids Drug Product Specification
16.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Purdue Pharma
16.2.1 Purdue Pharma Company Profile
16.2.2 Purdue Pharma Opioids Drug Product Specification
16.2.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mallinckrodt
16.3.1 Mallinckrodt Company Profile
16.3.2 Mallinckrodt Opioids Drug Product Specification
16.3.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Amneal Pharma
16.4.1 Amneal Pharma Company Profile
16.4.2 Amneal Pharma Opioids Drug Product Specification
16.4.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Collegium
16.5.1 Collegium Company Profile
16.5.2 Collegium Opioids Drug Product Specification
16.5.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 J&J
16.6.1 J&J Company Profile
16.6.2 J&J Opioids Drug Product Specification
16.6.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Endo
16.7.1 Endo Company Profile
16.7.2 Endo Opioids Drug Product Specification
16.7.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Pfizer
16.8.1 Pfizer Company Profile
16.8.2 Pfizer Opioids Drug Product Specification
16.8.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 INSYS
16.9.1 INSYS Company Profile
16.9.2 INSYS Opioids Drug Product Specification
16.9.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Mylan
16.10.1 Mylan Company Profile
16.10.2 Mylan Opioids Drug Product Specification
16.10.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Hikma
16.11.1 Hikma Company Profile
16.11.2 Hikma Opioids Drug Product Specification
16.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Egalet
16.12.1 Egalet Company Profile
16.12.2 Egalet Opioids Drug Product Specification
16.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Opioids Drug Manufacturing Cost Analysis
17.1 Opioids Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Opioids Drug
17.4 Opioids Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Opioids Drug Distributors List
18.3 Opioids Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Opioids Drug (2022-2027)
20.2 Global Forecasted Revenue of Opioids Drug (2022-2027)
20.3 Global Forecasted Price of Opioids Drug (2016-2027)
20.4 Global Forecasted Production of Opioids Drug by Region (2022-2027)
20.4.1 North America Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.3 Europe Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.7 Africa Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.9 South America Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Opioids Drug Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Opioids Drug by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Opioids Drug by Country
21.2 East Asia Market Forecasted Consumption of Opioids Drug by Country
21.3 Europe Market Forecasted Consumption of Opioids Drug by Countriy
21.4 South Asia Forecasted Consumption of Opioids Drug by Country
21.5 Southeast Asia Forecasted Consumption of Opioids Drug by Country
21.6 Middle East Forecasted Consumption of Opioids Drug by Country
21.7 Africa Forecasted Consumption of Opioids Drug by Country
21.8 Oceania Forecasted Consumption of Opioids Drug by Country
21.9 South America Forecasted Consumption of Opioids Drug by Country
21.10 Rest of the world Forecasted Consumption of Opioids Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioids Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioids Drug Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.5 Market by Application
1.5.1 Global Opioids Drug Market Share by Application: 2022-2027
1.5.2 Pain Relief
1.5.3 Anesthesia
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Opioids Drug Market
1.8.1 Global Opioids Drug Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Opioids Drug Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioids Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioids Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Opioids Drug Sales Volume Market Share by Region (2016-2021)
3.2 Global Opioids Drug Sales Revenue Market Share by Region (2016-2021)
3.3 North America Opioids Drug Sales Volume
3.3.1 North America Opioids Drug Sales Volume Growth Rate (2016-2021)
3.3.2 North America Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Opioids Drug Sales Volume
3.4.1 East Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Opioids Drug Sales Volume (2016-2021)
3.5.1 Europe Opioids Drug Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Opioids Drug Sales Volume (2016-2021)
3.6.1 South Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Opioids Drug Sales Volume (2016-2021)
3.7.1 Southeast Asia Opioids Drug Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Opioids Drug Sales Volume (2016-2021)
3.8.1 Middle East Opioids Drug Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Opioids Drug Sales Volume (2016-2021)
3.9.1 Africa Opioids Drug Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Opioids Drug Sales Volume (2016-2021)
3.10.1 Oceania Opioids Drug Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Opioids Drug Sales Volume (2016-2021)
3.11.1 South America Opioids Drug Sales Volume Growth Rate (2016-2021)
3.11.2 South America Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Opioids Drug Sales Volume (2016-2021)
3.12.1 Rest of the World Opioids Drug Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Opioids Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Opioids Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Opioids Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Opioids Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Opioids Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Opioids Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Opioids Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Opioids Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Opioids Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Opioids Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Opioids Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Opioids Drug Sales Volume Market Share by Type (2016-2021)
14.2 Global Opioids Drug Sales Revenue Market Share by Type (2016-2021)
14.3 Global Opioids Drug Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Opioids Drug Consumption Volume by Application (2016-2021)
15.2 Global Opioids Drug Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Opioids Drug Business
16.1 Teva
16.1.1 Teva Company Profile
16.1.2 Teva Opioids Drug Product Specification
16.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Purdue Pharma
16.2.1 Purdue Pharma Company Profile
16.2.2 Purdue Pharma Opioids Drug Product Specification
16.2.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mallinckrodt
16.3.1 Mallinckrodt Company Profile
16.3.2 Mallinckrodt Opioids Drug Product Specification
16.3.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Amneal Pharma
16.4.1 Amneal Pharma Company Profile
16.4.2 Amneal Pharma Opioids Drug Product Specification
16.4.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Collegium
16.5.1 Collegium Company Profile
16.5.2 Collegium Opioids Drug Product Specification
16.5.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 J&J
16.6.1 J&J Company Profile
16.6.2 J&J Opioids Drug Product Specification
16.6.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Endo
16.7.1 Endo Company Profile
16.7.2 Endo Opioids Drug Product Specification
16.7.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Pfizer
16.8.1 Pfizer Company Profile
16.8.2 Pfizer Opioids Drug Product Specification
16.8.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 INSYS
16.9.1 INSYS Company Profile
16.9.2 INSYS Opioids Drug Product Specification
16.9.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Mylan
16.10.1 Mylan Company Profile
16.10.2 Mylan Opioids Drug Product Specification
16.10.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Hikma
16.11.1 Hikma Company Profile
16.11.2 Hikma Opioids Drug Product Specification
16.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Egalet
16.12.1 Egalet Company Profile
16.12.2 Egalet Opioids Drug Product Specification
16.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Opioids Drug Manufacturing Cost Analysis
17.1 Opioids Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Opioids Drug
17.4 Opioids Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Opioids Drug Distributors List
18.3 Opioids Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Opioids Drug (2022-2027)
20.2 Global Forecasted Revenue of Opioids Drug (2022-2027)
20.3 Global Forecasted Price of Opioids Drug (2016-2027)
20.4 Global Forecasted Production of Opioids Drug by Region (2022-2027)
20.4.1 North America Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.3 Europe Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.7 Africa Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.9 South America Opioids Drug Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Opioids Drug Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Opioids Drug by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Opioids Drug by Country
21.2 East Asia Market Forecasted Consumption of Opioids Drug by Country
21.3 Europe Market Forecasted Consumption of Opioids Drug by Countriy
21.4 South Asia Forecasted Consumption of Opioids Drug by Country
21.5 Southeast Asia Forecasted Consumption of Opioids Drug by Country
21.6 Middle East Forecasted Consumption of Opioids Drug by Country
21.7 Africa Forecasted Consumption of Opioids Drug by Country
21.8 Oceania Forecasted Consumption of Opioids Drug by Country
21.9 South America Forecasted Consumption of Opioids Drug by Country
21.10 Rest of the world Forecasted Consumption of Opioids Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Opioids Drug Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
